These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36469628)

  • 1. Study on formulation and preparation technology of the composite cellulose-based enteric capsule shells.
    Liu L; Luo H; Yang Y; Huang J; Liu C; Ding Q; Zhang H
    Drug Dev Ind Pharm; 2022 Nov; 48(11):646-656. PubMed ID: 36469628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of formula factors on the properties of HPMC plant hollow capsule film.
    Ding H; He S; Luo W; Liu L; Wang S; Chen X
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1052-1063. PubMed ID: 33784225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of Parteck® SRP 80 and Hypromellose for Chronomodulated Release of LTD4 Receptor Antagonist and Statistical Optimization Using Central Composite Design.
    Jawed S; Cs S
    AAPS PharmSciTech; 2022 Sep; 23(7):263. PubMed ID: 36151401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y; Zhao F; Paborji M
    Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F; Jones BE
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The shell dissolution of various empty hard capsules.
    Chiwele I; Jones BE; Podczeck F
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
    Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
    Honkanen O; Laaksonen P; Marvola J; Eerikäinen S; Tuominen R; Marvola M
    Eur J Pharm Sci; 2002 Jun; 15(5):479-88. PubMed ID: 12036724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing hydroxypropyl methylcellulose/hydroxypropyl starch blends for use as capsule materials.
    Zhang L; Wang Y; Liu H; Yu L; Liu X; Chen L; Zhang N
    Carbohydr Polym; 2013 Oct; 98(1):73-9. PubMed ID: 23987318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M; Rothenhäusler B; Röthlisberger D
    Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
    Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPMC capsules: current status and future prospects.
    Al-Tabakha MM
    J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules.
    Ku MS; Lu Q; Li W; Chen Y
    Int J Pharm; 2011 Sep; 416(1):16-24. PubMed ID: 21356291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects.
    Wang CY; Ho HO; Lin LH; Lin YK; Sheu MT
    Int J Pharm; 2005 Jun; 297(1-2):89-97. PubMed ID: 15885936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wet film dimensions of capsule walls during dip coating.
    Keary CM; Heeschen WA
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1059-76. PubMed ID: 12455466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the influence of cellulose derivatives on physical and analytical attributes of a drug product belonging to BCS class II.
    Domosławska M; Pawlak-Morka R; Dobrzyński Ł; Herda M
    Polim Med; 2018; 48(2):83-90. PubMed ID: 31111692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
    Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
    Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugarcane Bagasse as the Source of Nanocrystalline Cellulose for Gelatin-Free Capsule Shell.
    Sabara Z; Mutmainnah A; Kalsum U; Afiah IN; Husna I; Saregar A; Irzaman ; Umam R
    Int J Biomater; 2022; 2022():9889127. PubMed ID: 35198027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.